Omega Healthcare Investors, Inc.

Thank you for standing by. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the Omega Healthcare Investors' fourth quarter earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed with the number one on your telephone keypad. If you would like to withdraw your question, press star 1 again. Thank you. I would now like to turn the call over to Michelle Reber. Please go ahead.

Thank you, and good morning. With me today is Omega's CEO, Taylor Pickett, President, Matthew Gorman, CFO, Bob Stevenson, CIO, Vikas Gupta, and Megan Krull, Senior Vice President of Operations. Comments made during this conference call that are not historical facts may be forward-looking statements, such as statements regarding our financial projections, potential transactions, operator prospects, and outlook generally. Factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the company's filings with the SEC. During the call today, we will refer to some non-GAAP financial measures, such as NAREIT FFO, adjusted FFO, FAD, and EBITDA. Reconciliations of these non-GAAP measures to the most comparable measure under generally accepted accounting principles are available in the quarterly supplement. In addition, certain operator coverage and financial information that we discuss is based on data provided by our operators that has not been independently verified by Omega. I will now turn the call over to Taylor.

Thanks, Michelle. Good morning, and thank you for joining our fourth quarter 2024 earnings conference call. Today I will discuss our fourth quarter financial results, management changes, and certain key operating trends. Fourth quarter FAD, funds available for distribution of 70 cents per share, reflects continued revenue and EBITDA growth, which has allowed us to reduce leverage to below 4.0 times debt to EBITDA while continuing to deliver FAD growth in 2024. Our 2025 AFFO guidance is $2.90 per share to $2.98 per share, which reflects the first quarter 2025 dilutive impact of our significant fourth quarter share issuances offset by escalators and other opportunities throughout 2025. We recently announced management changes with Matthew Gorman, named President, and Vikas Gupta named Chief Investment Officer. I am extremely confident in their ability to lead our exceptional team in the upcoming years. I would also like to thank Dan Booth. I had the opportunity to work with Dan for over 30 years, 23 years here at Omega. Dan's many contributions to Omega were an important driver of Omega's outperformance of not only other healthcare REITs, but all REITs over the last 23 years. Lastly, in 2024, the team did a great job staying disciplined while sourcing and closing 36 transactions, deploying approximately $1.1 billion in capital. The 2025 acquisition pipeline remains active. I will now turn the call over to Bob.